Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1992 Jun;47(6):418–420. doi: 10.1136/thx.47.6.418

Bone turnover during short course prednisolone treatment in patients with chronic obstructive airways disease.

D Morrison 1, N J Ali 1, P A Routledge 1, S Capewell 1
PMCID: PMC463804  PMID: 1496499

Abstract

BACKGROUND: Although osteoporosis is a well known side effect of long term prednisolone, the effects of a short course are less clear. Biochemical markers of bone turnover were therefore studied in 10 men with chronic obstructive airways disease who required assessment of "steroid reversibility" (mean age 65 years, mean FEV1 1.2 1). METHOD: Patients received, single blind, two weeks of placebo, four weeks of prednisolone 20 mg/day, and then two further weeks of placebo. RESULTS: The mean (SD) fasting urinary hydroxyproline:creatinine ratio, a marker of bone resorption, increased by 65% with prednisolone (from 8.9 (5.7) to 14.7 (8.5) mumol/mmol) and returned to baseline after placebo. Serum alkaline phosphatase, a marker of net bone formation, fell after prednisolone by 28% (from 113 (41) to 81 (30) IU/1). Substantial changes occurred after only two weeks of prednisolone. Serum osteocalcin, calcium, and phosphate concentrations did not change significantly. CONCLUSIONS: Short courses of prednisolone increased bone resorption and inhibited bone formation after two and four weeks.

Full text

PDF
418

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ali N. J., Capewell S., Ward M. J. Bone turnover during high dose inhaled corticosteroid treatment. Thorax. 1991 Mar;46(3):160–164. doi: 10.1136/thx.46.3.160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brown J. P., Delmas P. D., Malaval L., Edouard C., Chapuy M. C., Meunier P. J. Serum bone Gla-protein: a specific marker for bone formation in postmenopausal osteoporosis. Lancet. 1984 May 19;1(8386):1091–1093. doi: 10.1016/s0140-6736(84)92506-6. [DOI] [PubMed] [Google Scholar]
  3. CURTISS P. H., Jr, CLARK W. S., HERNDON C. H. Vertebral fractures resulting from prolonged cortisone and corticotropin therapy. J Am Med Assoc. 1954 Oct 2;156(5):467–469. doi: 10.1001/jama.1954.02950050007002. [DOI] [PubMed] [Google Scholar]
  4. Charles P., Poser J. W., Mosekilde L., Jensen F. T. Estimation of bone turnover evaluated by 47Ca-kinetics. Efficiency of serum bone gamma-carboxyglutamic acid-containing protein, serum alkaline phosphatase, and urinary hydroxyproline excretion. J Clin Invest. 1985 Dec;76(6):2254–2258. doi: 10.1172/JCI112234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Crompton G. K. Corticosteroids and bone mass in asthma. Br Med J (Clin Res Ed) 1987 Jan 10;294(6564):123–123. doi: 10.1136/bmj.294.6564.123-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Deding A., Tougaard L., Krogh Jensen M., Rodbro P. Bone changes during prednisone treatment. Acta Med Scand. 1977;202(4):253–255. doi: 10.1111/j.0954-6820.1977.tb16822.x. [DOI] [PubMed] [Google Scholar]
  7. Gennari C., Imbimbo B., Montagnani M., Bernini M., Nardi P., Avioli L. V. Effects of prednisone and deflazacort on mineral metabolism and parathyroid hormone activity in humans. Calcif Tissue Int. 1984 May;36(3):245–252. doi: 10.1007/BF02405325. [DOI] [PubMed] [Google Scholar]
  8. Hahn T. J. Corticosteroid-induced osteopenia. Arch Intern Med. 1978 May 15;138(Spec No):882–885. [PubMed] [Google Scholar]
  9. Hahn T. J., Halstead L. R., Strates B., Imbimbo B., Baran D. T. Comparison of subacute effects of oxazacort and prednisone on mineral metabolism in man. Calcif Tissue Int. 1980;31(2):109–115. doi: 10.1007/BF02407171. [DOI] [PubMed] [Google Scholar]
  10. Kivirikko K. I., Laitinen O., Prockop D. J. Modifications of a specific assay for hydroxyproline in urine. Anal Biochem. 1967 May;19(2):249–255. doi: 10.1016/0003-2697(67)90160-1. [DOI] [PubMed] [Google Scholar]
  11. Lukert B. P., Higgins J. C., Stoskopf M. M. Serum osteocalcin is increased in patients with hyperthyroidism and decreased in patients receiving glucocorticoids. J Clin Endocrinol Metab. 1986 May;62(5):1056–1058. doi: 10.1210/jcem-62-5-1056. [DOI] [PubMed] [Google Scholar]
  12. Lukert B. P., Raisz L. G. Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med. 1990 Mar 1;112(5):352–364. doi: 10.7326/0003-4819-112-5-352. [DOI] [PubMed] [Google Scholar]
  13. Matthews J. N., Altman D. G., Campbell M. J., Royston P. Analysis of serial measurements in medical research. BMJ. 1990 Jan 27;300(6719):230–235. doi: 10.1136/bmj.300.6719.230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Nielsen H. K., Thomsen K., Eriksen E. F., Charles P., Storm T., Mosekilde L. The effects of high-dose glucocorticoid administration on serum bone gamma carboxyglutamic acid-containing protein, serum alkaline phosphatase and vitamin D metabolites in normal subjects. Bone Miner. 1988 Apr;4(1):105–113. [PubMed] [Google Scholar]
  15. Nordin B. E. Diagnostic procedures in disorders of calcium metabolism. Clin Endocrinol (Oxf) 1978 Jan;8(1):55–67. doi: 10.1111/j.1365-2265.1978.tb01350.x. [DOI] [PubMed] [Google Scholar]
  16. Nordin B. E., Marshall D. H., Francis R. M., Crilly R. G. The effects of sex steroid and corticosteroid hormones on bone. J Steroid Biochem. 1981 Dec;15:171–174. doi: 10.1016/0022-4731(81)90272-7. [DOI] [PubMed] [Google Scholar]
  17. Reid D. M., Nicoll J. J., Smith M. A., Higgins B., Tothill P., Nuki G. Corticosteroids and bone mass in asthma: comparisons with rheumatoid arthritis and polymyalgia rheumatica. Br Med J (Clin Res Ed) 1986 Dec 6;293(6560):1463–1466. doi: 10.1136/bmj.293.6560.1463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Reid I. R., Chapman G. E., Fraser T. R., Davies A. D., Surus A. S., Meyer J., Huq N. L., Ibbertson H. K. Low serum osteocalcin levels in glucocorticoid-treated asthmatics. J Clin Endocrinol Metab. 1986 Feb;62(2):379–383. doi: 10.1210/jcem-62-2-379. [DOI] [PubMed] [Google Scholar]
  19. Reid I. R. Pathogenesis and treatment of steroid osteoporosis. Clin Endocrinol (Oxf) 1989 Jan;30(1):83–103. doi: 10.1111/j.1365-2265.1989.tb03730.x. [DOI] [PubMed] [Google Scholar]
  20. Rickers H., Deding A., Christiansen C., Rødbro P. Mineral loss in cortical and trabecular bone during high-dose prednisone treatment. Calcif Tissue Int. 1984 May;36(3):269–273. doi: 10.1007/BF02405329. [DOI] [PubMed] [Google Scholar]
  21. Rüegsegger P., Medici T. C., Anliker M. Corticosteroid-induced bone loss. A longitudinal study of alternate day therapy in patients with bronchial asthma using quantitative computed tomography. Eur J Clin Pharmacol. 1983;25(5):615–620. doi: 10.1007/BF00542348. [DOI] [PubMed] [Google Scholar]
  22. Smith R. Corticosteroids and osteoporosis. Thorax. 1990 Aug;45(8):573–578. doi: 10.1136/thx.45.8.573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Toogood J. H., Crilly R. G., Jones G., Nadeau J., Wells G. A. Effect of high-dose inhaled budesonide on calcium and phosphate metabolism and the risk of osteoporosis. Am Rev Respir Dis. 1988 Jul;138(1):57–61. doi: 10.1164/ajrccm/138.1.57. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES